September/October 2013

 

In this Issue

Understanding Glaucoma

Researchers share their insights into the disease, its diagnosis, and its treatment.

Issue

Insert

View the E-Dition

CHIEF MEDICAL EDITOR’S PAGE

The Crazy Ones

By Steven D. Vold, MD

The Literature

By Pradeep Y. Ramulu, MD, MHS, PhD

PEER REVIEW

Anterior Segment Imaging in Angle Closure

This technology has become a valuable tool for diagnosing, treating, and conducting research on angle closure.

By Robert M. Feldman, MD

LANDMARK STUDIES

Questions and Answers on AGIS Statistics

By Jeffrey Tennant, MD; Douglas E. Gaasterland, MD; E. Kenneth Sullivan, PhD; and Paul VanVeldhuisen, PhD

INTERNATIONAL PERSPECTIVES

Civil Society and Blindness From Glaucoma in Sub-Saharan Africa

Achieving cost-effective, sustainable care in this region.

By Milad Moddaber, MSc, and Karim F. Damji, MD, FRCSC, MBA

COVER STORIES

New Concepts in Our Understanding of Glaucoma

How dynamic pulsatile mechanisms determine aqueous outflow.

By Murray Johnstone, MD

Understanding Trabecular Meshwork Outflow

Its role in modulating aqueous humor outflow and IOP.

By Swarup S. Swaminathan; Dong-Jin Oh, PhD; Min Hyung Kang, PhD; Ramez I. Haddadin, MD; Guadalupe Villarreal Jr, MD; Marc Töteberg-Harms, MD; Ayan Chatterjee; and Douglas J. Rhee, MD

The Histopathological Findings of the Trabecular Outflow Pathway in Primary Open-Angle Glaucoma

What likely contributes to the pathogenesis of this disease?

By Haiyan Gong, MD, PhD

Uveoscleral Outflow

Current understanding and methods of measurement.

By Carol B. Toris, PhD

Optimizing Conventional Trabecular Meshwork Outflow

Methods by which to modulate flow through this pathway.

By Arthur J. Sit, SM, MD

Noninvasive Imaging of the Outflow Pathway

Update on OCT technology for visualizing Schlemm canal.

By Larry Kagemann, PhD, and Joel S. Schuman, MD

Schlemm Canal Surgery

Why you may not get the IOP low enough yet.

By David L. Epstein, MD, MMM

The Impact of Wound Healing on Glaucoma Therapy

These processes and the ophthalmologist’s ability to control them ultimately determine the long-term success of all glaucoma surgery.

By Alastair Lockwood, BM, BChir, MRCOphth, and Sir Peng Tee Khaw, PhD, FRCP, FRCS, FRCOphth, CBiol, FSB, FRCPath, FARVO, FMedSci

Genetics and Glaucoma

Research is revealing much about the inheritance of disease. Genetic testing is useful for patients with early-onset glaucoma and for some families with multiple members affected by normal-tension and primary open-angle.

By Janey L. Wiggs, MD, PhD

THERAPEUTICS UPDATE

Fixed-Combination Medical Therapy for Glaucoma

Three surgeons discuss the clinical scenarios in which they prescribe these drugs.

By L. Jay Katz, MD; Robert J. Noecker, MD, MBA; and James C. Tsai, MD, MBA

PRACTICE POINTERS

Building A Practice

The second installment in this three-part series focuses on sustainable, responsible growth.

By Elle Kaplan

INSIDE EYETUBE.NET

Placing a Tube Shunt After Descemet Stripping Endothelial Keratoplasty

By Nathan M. Radcliffe, MD
 

Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

Facebook Twitter

About Glaucoma Today

Glaucoma Today is mailed bimonthly (six times a year) to 11,519 glaucoma specialists, general ophthalmologists, and clinical optometrists who treat patients with glaucoma. Glaucoma Today delivers important information on recent research, surgical techniques, clinical strategies, and technology.

Website Design by Sides Media